{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T18:13:28Z","timestamp":1778004808057,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T00:00:00Z","timestamp":1510704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.tube.2017.11.006","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T15:47:45Z","timestamp":1510847265000},"page":"99-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines"],"prefix":"10.1016","volume":"108","author":[{"given":"Stephanie A.","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2576-8783","authenticated-orcid":false,"given":"Lisa","family":"Stockdale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-5984","authenticated-orcid":false,"given":"Rachel","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Sibley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Sarfas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew K.","family":"O'Shea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zita-Rose","family":"Manjaly Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iman","family":"Satti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike J.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2017.11.006_bib1","series-title":"WHO tuberculosis factsheet","author":"WHO","year":"2017"},{"key":"10.1016\/j.tube.2017.11.006_bib2","series-title":"Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response","author":"WHO","year":"2010"},{"key":"10.1016\/j.tube.2017.11.006_bib3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.tube.2017.11.006_bib4","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1128\/IAI.00287-09","article-title":"Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis","volume":"77","author":"Vordermeier","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2017.11.006_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tube.2004.09.009","article-title":"Evaluation of vaccines in the EU TB Vaccine Cluster using a Guinea pig aerosol infection model of tuberculosis","volume":"85","author":"Williams","year":"2005","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2017.11.006_bib6","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1128\/IAI.73.6.3814-3816.2005","article-title":"Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in Guinea Pigs","volume":"73","author":"Williams","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2017.11.006_bib7","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2017.11.006_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1086\/590185","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa","volume":"198","author":"Hawkridge","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2017.11.006_bib9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/eji.200939754","article-title":"Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells","volume":"40","author":"Scriba","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2017.11.006_bib10","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2017.11.006_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tube.2013.11.003","article-title":"A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data","volume":"94","author":"McShane","year":"2014","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2017.11.006_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/aje\/kwm375","article-title":"Time lines of infection and disease in human influenza: a review of volunteer challenge studies","volume":"167","author":"Carrat","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.tube.2017.11.006_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri2902","article-title":"Experimental human challenge infections can accelerate clinical malaria vaccine development","volume":"11","author":"Sauerwein","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.tube.2017.11.006_bib14","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1001\/jama.279.18.1423","article-title":"Volunteers in typhoid infection study will aid future vaccine development","volume":"279","author":"Marwick","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.tube.2017.11.006_bib15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/jcu.20476","article-title":"Sonographic findings of healthy volunteers infected with dengue virus","volume":"36","author":"Statler","year":"2008","journal-title":"J Clin Ultrasound"},{"key":"10.1016\/j.tube.2017.11.006_bib16","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/infdis\/jis012","article-title":"A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin","volume":"205","author":"Minassian","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2017.11.006_bib17","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/infdis\/jit647","article-title":"Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination","volume":"209","author":"Harris","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2017.11.006_bib18","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/infdis\/jiv482","article-title":"Optimization of a human bacille calmette-gu\u00e9rin challenge model: a tool to evaluate antimycobacterial immunity","volume":"212","author":"Minhinnick","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2017.11.006_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019840","article-title":"Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy","volume":"6","author":"Minassian","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2017.11.006_bib20","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1016\/j.vaccine.2014.08.009","article-title":"Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle","volume":"32","author":"Villarreal-Ramos","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2017.11.006_bib21","doi-asserted-by":"crossref","first-page":"a018564","DOI":"10.1101\/cshperspect.a018564","article-title":"Modeling tuberculosis in nonhuman primates","author":"Scanga","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.tube.2017.11.006_bib22","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/IAI.02850-14","article-title":"Monkey models of tuberculosis: lessons learned","volume":"83","author":"Pena","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2017.11.006_bib23","doi-asserted-by":"crossref","first-page":"11497","DOI":"10.1073\/pnas.201404898","article-title":"Divergent effect of bacillus Calmette-Gu\u00e9rin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research","volume":"98","author":"Langermans","year":"2001","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"10.1016\/j.tube.2017.11.006_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tube.2015.10.004","article-title":"Ultra low dose aerosol challenge with Mycobacterium tuberculosis leads to divergent outcomes in rhesus and cynomolgus macaques","volume":"96","author":"Sharpe","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2017.11.006_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.7120\/09627286.24.2.139","article-title":"Refinement of welfare through development of a quantitative system for assessment of lifetime experience","volume":"24","author":"Wolfensohn","year":"2015","journal-title":"Anim Welf"},{"key":"10.1016\/j.tube.2017.11.006_bib26","series-title":"NC3Rs","author":"NC3Rs","year":"2017"},{"key":"10.1016\/j.tube.2017.11.006_bib27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.14573\/altex.1607281","article-title":"Replacing, reducing and refining the use of animals in tuberculosis vaccine research","volume":"34","author":"Tanner","year":"2017","journal-title":"ALTEX"},{"key":"10.1016\/j.tube.2017.11.006_bib28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tube.2016.09.004","article-title":"Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations","volume":"101","author":"Sharpe","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2017.11.006_bib29","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/CVI.00079-10","article-title":"Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing","volume":"17","author":"Sharpe","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.tube.2017.11.006_bib30","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1128\/jcm.35.3.566-569.1997","article-title":"PCR identification of Mycobacterium bovis PCR Identification of Mycobacterium bovis BCG","volume":"35","author":"Talbot","year":"1997","journal-title":"J Clin Microbio"},{"key":"10.1016\/j.tube.2017.11.006_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0171906","article-title":"An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques","volume":"12","author":"Sharpe","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2017.11.006_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005264","article-title":"MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques","volume":"4","author":"Verreck","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2017.11.006_bib33","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.vaccine.2005.01.057","article-title":"Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model","volume":"23","author":"Kita","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2017.11.006_bib34","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1016\/j.vaccine.2007.01.014","article-title":"Evaluation of a novel vaccine (HVJ-liposome\/HSP65 DNA + IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB","volume":"25","author":"Okada","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2017.11.006_bib35","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1073\/pnas.0712077106","article-title":"Defined tuberculosis vaccine, Mtb72F\/AS02A, evidence of protection in cynomolgus monkeys","volume":"106","author":"Reed","year":"2009","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"10.1016\/j.tube.2017.11.006_bib36","first-page":"992","article-title":"Evaluation of the immunogenicity of Mycobacterium bovis BCG delivered by aerosol to the lungs of macaques","volume":"22","author":"White","year":"2015"},{"key":"10.1016\/j.tube.2017.11.006_bib37","first-page":"351","article-title":"Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin","volume":"107","author":"Barclay","year":"1973","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.tube.2017.11.006_bib38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.tube.2008.05.002","article-title":"Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence","volume":"88","author":"Ganguly","year":"2008","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2017.11.006_bib39","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S2213-2600(15)00435-X","article-title":"First Human Immunization with A Live-Attenuated Mycobacterium tuberculosis: a randomized, double-blind, controlled phase I trial","volume":"3","author":"Spertini","year":"2015","journal-title":"Lancet Respir Med"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979217303190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979217303190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:41:08Z","timestamp":1761468068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979217303190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":39,"alternative-id":["S1472979217303190"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2017.11.006","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2017.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}